Mohamed Benderdour Selected Research

isocitrate dehydrogenase (NADP+)

11/2004	Decreased cardiac mitochondrial NADP+-isocitrate dehydrogenase activity and expression: a marker of oxidative stress in hypertrophy development.
11/2003	Cardiac mitochondrial NADP+-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation: an event that precedes hypertrophy development.
10/2002	Reverse flux through cardiac NADP(+)-isocitrate dehydrogenase under normoxia and ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohamed Benderdour Research Topics

Disease

15	Osteoarthritis 01/2020 - 08/2004
14	Inflammation (Inflammations) 12/2020 - 03/2005
6	Arthritis (Polyarthritis) 12/2019 - 07/2008
5	Rheumatoid Arthritis 01/2018 - 07/2008
2	Fibrosis (Cirrhosis) 04/2013 - 10/2012
2	Osteoporosis 01/2011 - 08/2004
2	Necrosis 01/2011 - 01/2006
2	Ischemia 08/2010 - 10/2002
2	Hypertrophy 11/2004 - 11/2003
1	Hypersensitivity (Allergy) 12/2022
1	Multiple Abnormalities 10/2021
1	Hemolysis 01/2020
1	Bone Resorption 12/2019
1	Heart Diseases (Heart Disease) 10/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2012
1	Anhedonia 11/2011
1	Infarction (Infarctions) 11/2011
1	Neoplasms (Cancer) 01/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2010
1	Reperfusion Injury 08/2010
1	Contusions 03/2009
1	Spinal Cord Injuries (Spinal Cord Injury) 03/2009
1	Disease Progression 01/2007
1	Bone Diseases (Bone Disease) 03/2005
1	Cardiomegaly (Heart Hypertrophy) 11/2003

Drug/Important Bio-Agent (IBA)

6	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 08/2017 - 11/2003
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2004
5	EnzymesIBA 12/2019 - 11/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 07/2008
3	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 12/2020 - 06/2013
3	LipocalinsIBA 12/2020 - 06/2013
3	Prostaglandin D2IBA 12/2020 - 01/2017
3	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2011
3	CytokinesIBA 01/2020 - 11/2011
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018 - 07/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2006
3	Dinoprostone (PGE2)FDA Link 05/2014 - 01/2006
3	ChitosanIBA 01/2012 - 07/2008
3	isocitrate dehydrogenase (NADP+)IBA 11/2004 - 10/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 07/2012
2	resolvin D1IBA 12/2019 - 08/2016
2	CollagenIBA 12/2019 - 01/2018
2	ProstaglandinsIBA 01/2017 - 01/2011
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2013 - 03/2012
2	Ramipril (Altace)FDA LinkGeneric 04/2013 - 10/2012
2	Interleukin-1beta (Interleukin 1 beta)IBA 01/2011 - 01/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2011 - 01/2011
2	Interleukin-1 (Interleukin 1)IBA 07/2008 - 01/2007
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2005 - 08/2004
1	MetalsIBA 12/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Durapatite (Hydroxylapatite)IBA 12/2019
1	Biological ProductsIBA 12/2019
1	Cathepsin KIBA 12/2019
1	Therapeutic UsesIBA 12/2019
1	monomethoxypolyethyleneglycol- cholesteryl esterIBA 01/2018
1	prostaglandin D2 receptorIBA 01/2017
1	gingerolIBA 01/2017
1	ProtandimIBA 01/2017
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 08/2016
1	ImmunosorbentsIBA 08/2016
1	pentosidineIBA 09/2014
1	CarnosineIBA 09/2014
1	AldehydesIBA 09/2014
1	Hyaluronic Acid (Hyaluronan)IBA 08/2014
1	Sorbitol (Yal)FDA Link 08/2014
1	Prostaglandin-E SynthasesIBA 05/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2012
1	Type 1 Angiotensin ReceptorIBA 10/2012
1	Pharmaceutical PreparationsIBA 10/2012
1	salicylhydroxamic acid (SHAM)IBA 11/2011
1	Escitalopram FDA Link 11/2011
1	Sucrose (Saccharose)IBA 11/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2011
1	thymoquinoneIBA 01/2011
1	Caspase 3 (Caspase-3)IBA 01/2011
1	Peptides (Polypeptides)IBA 08/2010
1	Connexin 43 (Connexin43)IBA 08/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2009
1	Atorvastatin (Lipitor)FDA Link 03/2009
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2008
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2008
1	PPAR gammaIBA 01/2007
1	Interleukin-6 (Interleukin 6)IBA 01/2006
1	Messenger RNA (mRNA)IBA 11/2004
1	Succinic Acid (Succinate)IBA 10/2002
1	Citric Acid (Citrate)FDA LinkGeneric 10/2002

Therapy/Procedure

1	Knee Replacement Arthroplasty (Total Knee Replacement) 12/2022
1	Oral Administration 10/2012
1	Therapeutics 01/2011